| Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial D Annane, S Siami, S Jaber, C Martin, S Elatrous, AD Declère, JC Preiser, ... Jama 310 (17), 1809-1817, 2013 | 867 | 2013 |
| Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study Intensive care medicine 47, 60-73, 2021 | 456 | 2021 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 436 | 2021 |
| Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction B Levy, R Clere-Jehl, A Legras, T Morichau-Beauchant, M Leone, ... Journal of the American College of Cardiology 72 (2), 173-182, 2018 | 378 | 2018 |
| Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial S Ehrmann, J Li, M Ibarra-Estrada, Y Perez, I Pavlov, B McNicholas, ... The Lancet Respiratory Medicine 9 (12), 1387-1395, 2021 | 351 | 2021 |
| Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled … F Ader, M Bouscambert-Duchamp, M Hites, N Peiffer-Smadja, J Poissy, ... The Lancet infectious diseases 22 (2), 209-221, 2022 | 343 | 2022 |
| Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside B Levy, S Collin, N Sennoun, N Ducrocq, A Kimmoun, P Asfar, P Perez, ... Intensive care medicine 36, 2019-2029, 2010 | 239 | 2010 |
| Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort N Néant, G Lingas, Q Le Hingrat, J Ghosn, I Engelmann, Q Lepiller, ... Proceedings of the National Academy of Sciences 118 (8), e2017962118, 2021 | 199 | 2021 |
| Vasoplegia treatments: the past, the present, and the future B Levy, C Fritz, E Tahon, A Jacquot, T Auchet, A Kimmoun Critical care 22, 1-11, 2018 | 181 | 2018 |
| Hemodynamic consequences of severe lactic acidosis in shock states: from bench to bedside A Kimmoun, E Novy, T Auchet, N Ducrocq, B Levy Critical Care 19, 1-13, 2016 | 175 | 2016 |
| Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases N Meneveau, B Guillon, B Planquette, G Piton, A Kimmoun, ... European heart journal 39 (47), 4196-4204, 2018 | 164 | 2018 |
| Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients V Léopold, E Gayat, R Pirracchio, J Spinar, J Parenica, T Tarvasmäki, ... Intensive care medicine 44, 847-856, 2018 | 149 | 2018 |
| Changes in cardiac arrest patients’ temperature management after the 2013 “TTM” trial: results from an international survey N Deye, F Vincent, P Michel, S Ehrmann, D Da Silva, M Piagnerelli, ... Annals of intensive care 6, 1-9, 2016 | 131 | 2016 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 128 | 2022 |
| Venoarterial extracorporeal membrane oxygenation to rescue sepsis-induced cardiogenic shock: a retrospective, multicentre, international cohort study N Bréchot, D Hajage, A Kimmoun, J Demiselle, C Agerstrand, S Montero, ... The Lancet 396 (10250), 545-552, 2020 | 117 | 2020 |
| An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 F Ader, N Peiffer-Smadja, J Poissy, M Bouscambert-Duchamp, D Belhadi, ... Clinical Microbiology and Infection 27 (12), 1826-1837, 2021 | 105 | 2021 |
| Prolonged prone positioning under VV-ECMO is safe and improves oxygenation and respiratory compliance A Kimmoun, S Roche, C Bridey, F Vanhuyse, R Fay, N Girerd, D Mandry, ... Annals of intensive care 5, 1-7, 2015 | 99 | 2015 |
| β1-adrenergic inhibition improves cardiac and vascular function in experimental septic shock A Kimmoun, H Louis, N Al Kattani, J Delemazure, N Dessales, C Wei, ... Critical care medicine 43 (9), e332-e340, 2015 | 81 | 2015 |
| COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study Infection 49 (5), 889-905, 2021 | 80 | 2021 |
| Temporal trends in mortality and readmission after acute heart failure: a systematic review and meta‐regression in the past four decades A Kimmoun, K Takagi, E Gall, S Ishihara, P Hammoum, N El Beze, ... European Journal of Heart Failure 23 (3), 420-431, 2021 | 75 | 2021 |
bruno levyNancyVerified email at sfr.fr
